Related Experiment Video

Updated: Sep 11, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.1K

Role of viral co-detections in young children with RSV infection

Cristina Garcia-Mauriño1, Helena Brenes-Chacon2, Cristina Tomatis-Souverbielle3

  • 1Barcelona Institute for Global Health (ISGlobal), Universitat de Barcelona, Spain.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|August 12, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Respiratory syncytial virusclinical disease severity scoreviral co-detections

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.0K

Related Experiment Videos

Last Updated: Sep 11, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.1K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.0K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K

Articles linked to this work by shared authors, journal, and citation graph.

Single-cell map of the healthy human immune system across the lifespan reveals unique infant immune signatures.

Nature communications·2026

Urinary tract infection in the neonatal intensive care unit.

Journal of perinatology : official journal of the California Perinatal Association·2026

B cell imprinting in children impairs antibodies to the haemagglutinin stalk.

Nature·2026

A systems immunology approach reveals divergent immune profiles of RSV and SARS-CoV-2 infections in infants.

Science translational medicine·2026

Epidemiology and Outcomes of Pediatric Fever in a Rural District of Southern Mozambique: 17 Years of Morbidity Surveillance.

Open forum infectious diseases·2025

SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody Transfer.

The Pediatric infectious disease journal·2025

Relationship between Antibiotic Prescription and Survival in Hospice.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Use of Whole Genome Sequencing to Investigate the Risk for Transmission of Clostridioides difficile From Prior Room Occupants: A Single-Center Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Histoplasma Capsulatum Antigen Persistence and Rate of Decay During Treatment of Histoplasmosis Varies by Immune Status.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Reducing Empiric Vancomycin Use in the Pediatric Intensive Care Unit: a Multicenter Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Characterizing measles healthcare facility exposures-December 2023-September 2025-New York City.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us